MKI67 and neoplasm: Notably, immunohistochemistry (IHC) analysis revealed no change in Ki-67 staining in primary tumor mass in the two groups, thus confirming that CAF MSI2 does not play a significant role in NSCLC tumor growth (Fig. 3G).